How to manage pain in the ER: Ask the patient.
2015-06-12
(Press-News.org) WASHINGTON --Simply asking the question, "Do you want more pain medication?" resulted in satisfactory pain control in 99 percent of emergency department patients participating in a study. The study of a new evidence-based protocol to treat acute, severe pain in emergency department patients was published online yesterday in Annals of Emergency Medicine ("Efficacy of an Acute Pain Titration Protocol Driven by Patient Response to a Simply Query: 'Do You Want More Pain Medication?'").
"The crowded conditions in most emergency departments in the U.S. are not conducive to fully individualized pain treatment," said Andrew Chang, MD, MS of the Department of Emergency Medicine at Montefiore Medical Center in Bronx, N.Y. "Our simple and easy to remember '1 + 1 + 1 + 1' protocol holds promise for safely providing adequate pain relief to patients with acute severe pain."
Researchers provided 1 milligram of intravenous (IV) hydromorphone to adult patients reporting acute, severe pain. Thirty minutes later, the patient was asked, "Do you want more pain medication?" The patient was then asked the same question at 30-minute intervals and given an additional 1 milligram IV hydromorphone each time he/she answered "yes."
Of the 207 patients enrolled in the study, 114 received 1 milligram of hydromorphone (the initial dose), 78 received 2 milligrams, nine received 3 milligrams and six received 4 milligrams. All but two of the patients achieved satisfactory pain control within 2 to 4 hours (the study period's duration). Almost all of the patients were satisfied with their pain treatment: 67 percent reported being very satisfied and 29 percent reported being satisfied.
"Pain perception is highly subjective and not necessarily correlated to pain scores," said Dr. Chang. "Our pain protocol is a departure from the more traditional ways of assessing pain relief, which typically use the visual analog scale or the numerical rating scale. Instead, our use of a non-numerical, simple yes/no question offers patients the ability to decide for themselves whether their pain is adequately controlled and allows them to balance pain relief against medication side effects such as nausea and drowsiness. This likely explains the wide range of pain scores (as much as 0 to ten) for patients who did not ask for pain medication."
INFORMATION:
Annals of Emergency Medicine is the peer-reviewed scientific journal for the American College of Emergency Physicians, the national medical society representing emergency medicine. ACEP is committed to advancing emergency care through continuing education, research, and public education. Headquartered in Dallas, Texas, ACEP has 53 chapters representing each state, as well as Puerto Rico and the District of Columbia. A Government Services Chapter represents emergency physicians employed by military branches and other government agencies. For more information, visit http://www.acep.org.
ELSE PRESS RELEASES FROM THIS DATE:
2015-06-12
A recent study from the University of Eastern Finland in collaboration with Deakin University, Australia, shows that recurrent major depressive disorder (MDD) in men is associated with lower bone density. The use of antidepressants was also associated with lower bone mineral density (BMD), but this association was dependent on the person's weight and site of bone measurement.
Osteoporosis is a common disorder and an underlying factor in fragility fractures. Especially in women, the menopause increases the risk of osteoporosis. Other risk factors include low levels of ...
2015-06-12
The team headed by Dr. Kathrin Suttner, who, together with Prof. Dr. Carsten Schmidt-Weber, heads the airway immunology research group at the Helmholtz Zentrum München and Technische Universität München, concentrated its work on the so-called naive CD4+ T cells. They are a precursor form of T cells and form the basis for immunological memory*. Impaired development of these cells can influence the entire immune system and lead to illnesses such as allergies and asthma.
Protein atlas on T cell precursors
The scientists specifically examined proteins on ...
2015-06-12
Clinicians at Ludwig-Maximilians-Universitaet (LMU) in Munich have elucidated a mechanism involved in determining the lifespan of antibody-producing cells, and identified a promising new biomarker for monitoring autoimmune diseases like multiple sclerosis and lupus erythematosus.
The so-called humoral immune response is mediated by plasma cells and plays a central role in combating infections. Plasma cells secrete antibodies - a class of proteins that specifically recognize infectious pathogens and facilitate their destruction. Individual plasma cells make only a single ...
2015-06-12
Rome, Italy, 12 June 2015: The results of a systematic review of published studies presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) Press Conference showed that biologics improve both absenteeism (not showing up for work) and presenteeism (being at work but not functioning fully) in patients with chronic inflammatory arthritides. Rheumatic conditions are the most frequently cited reason for absence from work, and these findings suggest that biologics could significantly reduce the economic burden of these diseases.
Chronic inflammatory ...
2015-06-12
Rome, Italy, 12 June 2015: The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) Press Conference showed that people with rheumatoid arthritis (RA) are less likely to be protected by hepatitis B vaccination than the general population. Within the trial only 11% of those with the condition responded to the vaccine, compared with 83% of those without RA, suggesting that people with RA may still be at risk of infection in spite of vaccination.
"The majority of RA patients tested as part of our study were not protected ...
2015-06-12
Rome, Italy, 12 June 2015: The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) showed that inspiratory muscle training (IMT) significantly improves lung strength and efficiency in patients with ankylosing spondylitis (AS), a condition often associated with breathing difficulties. These findings demonstrate that just eight weeks of IMT provide greater improvements in lung function than conventional treatment options.
AS is a painful and progressive form of arthritis caused by chronic inflammation of the joints ...
2015-06-12
Rome, Italy, 12 June 2015: The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) demonstrated for the first time that treatment-naive patients with early Rheumatoid Arthritis (RA) have myocardial and vascular abnormalities, even at the earliest stage of their disease. These findings suggest that patients may develop early cardiomyopathy (disease of the heart muscle), increasing their risk of cardiovascular morbidity and mortality from the time of their diagnosis. Cardiomyopathy is a serious condition and a leading ...
2015-06-12
Rome, Italy, 12 June 2015: The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) identified that the cytokine (cell signalling protein) Interleukin-1β (IL-1β) is a crucial factor in the development of blood-induced cartilage damage. This finding opens up the possibility that a treatment targeting IL-1β could provide a new way to protect cartilage after a joint bleed, which in turn should significantly reduce subsequent disability.1
Exposure of joint cartilage to blood can occur after joint trauma, ...
2015-06-12
Rome, Italy, 12 June 2015: Two new studies presented at the European League Against Rheumatism Annual Congress (EULAR 2015) have shown the importance of using ultrasound to identify those Rheumatoid Arthritis (RA) patients in clinical remission who would benefit from more intensive treatment.
Many patients deemed to be in clinical remission still have active joint disease without any obvious symptoms or physical signs, but with risk of further progression of joint damage. Using ultrasound to predict the risk of flare and exacerbation of symptoms will allow these patients ...
2015-06-12
Rome, Italy, 12 June 2015: The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) Press Conference showed that the chickenpox (varicella) vaccine can be effective and safe even in children with paediatric rheumatic disease receiving immunosuppression treatment. By using a checklist to pre-screen children, the investigators were able to identify diverse patient groups suitable for vaccination, protecting them from a potentially life-threatening infection.
Rheumatic diseases are autoimmune diseases, arising when the ...
LAST 30 PRESS RELEASES:
[Press-News.org] How to manage pain in the ER: Ask the patient.